搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
Hollywood Life
6 小时
Naveen Jain’s New Book The Youth Formula Imagines a World Where Aging is Optional
Most people have also heard that they should do infrared saunas to reverse aging or that longevity drugs like Metformin and ...
1 天
Researcher touts promise of drug to treat Alzheimer's during Tulsa event
Officials said over 71,000 Oklahomans are currently living with Alzheimer's disease. Nationally, that number is approaching 7 ...
1 天
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Regains Compliance For ...
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Regains Compliance For Continued Listing on Nasdaq ...
Managingip.com
1 天
Weighing ‘reasonable expectation of success’ in drug patent inventiveness assessments ...
The patent at issue is the Chinese invention patent No. 200780004302.4 owned by Novartis AG, which is entitled ‘Use of ...
Medindia
2 天
Microneedle Sensors for Real-Time Biomarker Detection
The rapid evolution in personalized healthcare has driven the development of wearable biomedical devices, with microneedle ...
4 天
I'm a longevity researcher and doctor of functional medicine: Here's what I do every day ...
Dr. Frank Lipman has over 35 years of experience in functional medicine, and now focuses on longevity. Here are his daily ...
MyChesCo on MSN
5 天
Palvella Therapeutics Begins Phase 3 Trial for Microcystic Lymphatic Malformations Treatment
Palvella Therapeutics, Inc. has announced the commencement of dosing in its Phase 3 SELVA trial, aimed at evaluating QTORIN™ ...
The Daily Telegraph
5 天
Can taking rapamycin really stop me ageing?
Rapamycin is a drug commonly prescribed to organ transplant patients to suppress their immune response. However, some experts ...
6 天
Pieris Pharmaceuticals announces first patient dosed in SELVA Phase 3 trial
Palvella Therapeutics announced the first patient has been dosed in SELVA, a multicenter, Phase 3 clinical trial designed to evaluate the ...
manilatimes
7 天
Palisade Bio Announces First Subject Dosed in Phase 1 Clinical Study of PALI-2108 for the ...
Carlsbad, CA, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) ("Palisade,” "Palisade Bio” or the "Company”), a biopharmaceutical company focused on developing and advancing novel ...
manilatimes
9 天
Umoja Biopharma Announces Oral and Poster Presentations at the 66th American Society of ...
Presentation Date/Time: Saturday, December 7, 2024, 5:30 p.m. PT Presenting Speaker: Alissa Brandes, Ph.D.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈